Healthcare real estate investment trust HCP Inc. is looking to sell up to $750.0 million of its common stock from time to time under an at-the-market equity offering program.
In this regard, the company struck a deal May 31 with J.P. Morgan Securities LLC, Merrill Lynch Pierce Fenner & Smith Inc., UBS Securities LLC, Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC, Credit Agricole Securities (USA) Inc., Goldman Sachs & Co. LLC, RBC Capital Markets LLC and BNY Mellon Capital Markets LLC, as sales agents.
HCP plans to use the net proceeds for general corporate purposes, including future acquisitions and investments or repayment of debt, including borrowings outstanding under its revolving credit facility.
